drugset / Trial / NCT00734604

A Study for Patients With Erectile Dysfunction to Test Whether Tadalafil Taken Once a Day Can Better Improve Psychological Outcomes.

NCT00734604

Phase 3 Completed 378 enrolled Eli Lilly and Company
RandomizedCrossoverOpen-labelTreatment

Summary

The primary purpose of the study is to help answer whether tadalafil taken once a day can help improve the psychological outcomes (such as sexual self confidence, spontaneity and time concerns) compared to sildenafil taken as needed in patients with erectile dysfunction (ED).

Timeline

Start
2008-08
Primary completion
2009-09
Completion
2009-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Sildenafil Unknown 100 mg Oral
Subject Tadalafil Small molecule 5 mg Oral
Subject Tadalafil Small molecule 20 mg Oral

Indications